WBA250117P16000
- 4.00
- -0.66-14.16%
Walgreens Boots Alliance Newsroom
RBC Capital Maintains Walgreens Boots Alliance(WBA.US) With Hold Rating, Raises Target Price to $12
RBC Capital Remains a Hold on Walgreens Boots Alliance (WBA)
Analysts Offer Insights on Healthcare Companies: Xeris Pharmaceuticals (XERS), Quanterix (QTRX) and Walgreens Boots Alliance (WBA)
Express News | Walgreens : RBC Raises Target Price to $12 From $9
Walgreens Boots Alliance Options Spot-On: On January 14th, 121.45K Contracts Were Traded, With 1.07 Million Open Interest
On January 14th ET, $Walgreens Boots Alliance(WBA.US)$ had active options trading, with a total trading volume of 121.45K options for the day, of which put options accounted for 26.22% of the total
A Quick Look at Today's Ratings for Walgreens Boots Alliance(WBA.US), With a Forecast Between $7 to $15
Walgreens Boots Alliance Options Spot-On: On January 13th, 143.87K Contracts Were Traded, With 1.08 Million Open Interest
On January 13th ET, $Walgreens Boots Alliance(WBA.US)$ had active options trading, with a total trading volume of 143.87K options for the day, of which put options accounted for 34.38% of the total
Jefferies Adjusts Walgreens Boots Alliance Price Target to $11 From $9
TD Cowen Adjusts Price Target on Walgreens Boots Alliance to $15 From $14
Evercore ISI Group Maintains In-Line on Walgreens Boots Alliance, Raises Price Target to $12
Jim Cramer: Walgreens' (WBA) Plan to Close Stores and Cut Costs – A Path to Recovery?
Walgreens Boots Alliance Is Maintained at Underperform by B of A Securities
Walgreens Boots Alliance Analyst Ratings
Truist Financial Sticks to Its Hold Rating for Walgreens Boots Alliance (WBA)
BofA Securities Maintains Walgreens Boots Alliance(WBA.US) With Sell Rating, Raises Target Price to $8.5
Express News | Walgreens Boots Alliance : Deutsche Bank Raises Target Price to $11 From $10
Challenges in Profitability and Financial Flexibility Lead to Sell Rating on Walgreens Boots Alliance
Express News | RPT-Buzz-US Stocks Weekly: Seesaw
U.S. Stock Market Insights | Delta Air Lines has scored big! Stock prices hit a new high, with performance and outlook both exceeding expectations; a $16.4 billion acquisition of Calpine, Energy giant CEG surged by 25.16%.
The Medical merger and acquisition frenzy has started again! It is rumored that Johnson & Johnson is in talks to acquire the biopharmaceutical company Intra-Cellular Therapies Inc., which focuses on treating central nervous system diseases, and its stock price has soared nearly 15%.
Dow Tumbles Around 700 Points Following Jobs Data, Investor Sentiment Dips Further: Greed Index Remains In 'Fear' Zone